Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.

<h4>Unlabelled</h4>Hepatitis B virus (HBV) infection is one of the most frequent causes of chronic liver disease worldwide. Because recent studies have suggested that Toll-like receptor (TLR)-based therapies may be a promising approach in the treatment of HBV infection, we studied the role of the lo... View More